NEW YORK (GenomeWeb News) – Axxam has licensed Genedata’s data analysis and management software for use in its high-throughput screening programs, Genedata said today.
 
The multi-year agreement allows Axxam to implement the Genedata Screener software.
 
Axxam CEO Stefan Lohmer said the company’s focus extends beyond the actual license agreement to “a comprehensive, long-term partnership in high throughput screening.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.